PMC:7534795 / 575-851 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T7","span":{"begin":40,"end":55},"obj":"Disease"},{"id":"T8","span":{"begin":46,"end":55},"obj":"Disease"},{"id":"T9","span":{"begin":211,"end":219},"obj":"Disease"}],"attributes":[{"id":"A7","pred":"mondo_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/MONDO_0005108"},{"id":"A8","pred":"mondo_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A9","pred":"mondo_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"m. A plethora of studies have shown the viral infection triggers an exaggerated immune response, hypercoagulation and oxidative stress, which contribute significantly to poor cardiovascular outcomes observed in COVID-19 patients. To date, there are no approved vaccines or the"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T17496","span":{"begin":3,"end":4},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"m. A plethora of studies have shown the viral infection triggers an exaggerated immune response, hypercoagulation and oxidative stress, which contribute significantly to poor cardiovascular outcomes observed in COVID-19 patients. To date, there are no approved vaccines or the"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T43168","span":{"begin":40,"end":55},"obj":"http://purl.obolibrary.org/obo/GO_0016032"},{"id":"T50540","span":{"begin":80,"end":95},"obj":"http://purl.obolibrary.org/obo/GO_0006955"}],"text":"m. A plethora of studies have shown the viral infection triggers an exaggerated immune response, hypercoagulation and oxidative stress, which contribute significantly to poor cardiovascular outcomes observed in COVID-19 patients. To date, there are no approved vaccines or the"}

{"project":"LitCovid-sentences","denotations":[{"id":"T5","span":{"begin":3,"end":229},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"m. A plethora of studies have shown the viral infection triggers an exaggerated immune response, hypercoagulation and oxidative stress, which contribute significantly to poor cardiovascular outcomes observed in COVID-19 patients. To date, there are no approved vaccines or the"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T1","span":{"begin":5,"end":13},"obj":"Phenotype"},{"id":"T2","span":{"begin":118,"end":134},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/HP_0001050"},{"id":"A2","pred":"hp_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/HP_0025464"}],"text":"m. A plethora of studies have shown the viral infection triggers an exaggerated immune response, hypercoagulation and oxidative stress, which contribute significantly to poor cardiovascular outcomes observed in COVID-19 patients. To date, there are no approved vaccines or the"}

{"project":"LitCovid-PubTator","denotations":[{"id":"39","span":{"begin":220,"end":228},"obj":"Species"},{"id":"55","span":{"begin":40,"end":55},"obj":"Disease"},{"id":"56","span":{"begin":97,"end":113},"obj":"Disease"},{"id":"57","span":{"begin":211,"end":219},"obj":"Disease"}],"attributes":[{"id":"A39","pred":"tao:has_database_id","subj":"39","obj":"Tax:9606"},{"id":"A55","pred":"tao:has_database_id","subj":"55","obj":"MESH:D001102"},{"id":"A56","pred":"tao:has_database_id","subj":"56","obj":"MESH:D019851"},{"id":"A57","pred":"tao:has_database_id","subj":"57","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"m. A plethora of studies have shown the viral infection triggers an exaggerated immune response, hypercoagulation and oxidative stress, which contribute significantly to poor cardiovascular outcomes observed in COVID-19 patients. To date, there are no approved vaccines or the"}